Année d’arrivée au Centre
2017
Parcours professionnel
- Service de Neurologie MAZARIN 2, Groupement hospitalier de la Pitié Salpétrière, Paris
Formation
- DES d’oncologie, UFR de Santé de ROUEN, Université de ROUEN-Normandie
- DIU de Neuro-oncologie, université Paris La Sorbonne
Interventions pratiquées ou expertise
- Spécialisé en Neuro-oncologie
Sociétés savantes
- ANOCEF, membre du conseil d’administration
Publications majeures
- Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients. Support Care Cancer. 2019 Feb;27(2):477-484
- Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma. Oncotarget. 2017 Jul 18;8(29):48157-48168
- TERTp Mutation Detection in Plasma by Droplet-Digital Polymerase Chain Reaction in Spinal Myxopapillary Ependymoma With Lung Metastases
World Neurosurg. 2019 Oct;130:405-409 - Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma.
Acta Neuropathol Commun. 2020 Apr 17;8(1):52 - Major response to temozolomide as first-line treatment for newly-diagnosed DDR2-mutated glioblastoma: A case report.
Rev Neurol (Paris). 2020 Mar 2:S0035-3787(20)30396-9